Variant report
Variant | nsv963733 |
---|---|
Chromosome Location | chr2:152042812-152045126 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:10)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:10 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr2:152042718-152042947 | A549 | lung: | n/a | n/a |
2 | CEBPB | chr2:152042648-152042868 | K562 | blood: | n/a | n/a |
3 | CEBPB | chr2:152042639-152042984 | HepG2 | liver: | n/a | n/a |
4 | CEBPB | chr2:152042695-152042948 | K562 | blood: | n/a | n/a |
5 | POLR2A | chr2:152045098-152045276 | K562 | blood: | n/a | n/a |
6 | POLR2A | chr2:152044783-152044919 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | POLR2A | chr2:152042818-152044072 | K562 | blood: | n/a | n/a |
8 | POLR2A | chr2:152044290-152044511 | K562 | blood: | n/a | n/a |
9 | POLR2A | chr2:152044741-152044836 | K562 | blood: | n/a | n/a |
10 | YY1 | chr2:152042593-152042820 | K562 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000236885 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs566521358 | chr2:152042835-152042836 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs184210462 | chr2:152042856-152042857 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs112428407 | chr2:152042867-152042868 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs552176687 | chr2:152042887-152042888 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs190268558 | chr2:152042890-152042891 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs372580579 | chr2:152042908-152042909 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs554850121 | chr2:152042991-152042992 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs536152352 | chr2:152043026-152043027 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs574547233 | chr2:152043041-152043042 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs542217173 | chr2:152043057-152043058 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs73970408 | chr2:152043066-152043067 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs553987041 | chr2:152043084-152043085 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs41407949 | chr2:152043097-152043098 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs369784982 | chr2:152043102-152043103 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs538868869 | chr2:152043130-152043131 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs545822305 | chr2:152043154-152043155 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs34276187 | chr2:152043161-152043162 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs576372042 | chr2:152043168-152043169 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs181920104 | chr2:152043183-152043184 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs561998187 | chr2:152043187-152043188 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs527890861 | chr2:152043189-152043190 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs543226366 | chr2:152043190-152043191 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs564721251 | chr2:152043214-152043215 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs187372184 | chr2:152043222-152043223 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs71902387 | chr2:152043306-152043307 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs539133597 | chr2:152043325-152043326 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs58606828 | chr2:152043330-152043331 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs371702952 | chr2:152043331-152043332 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs560013239 | chr2:152043347-152043348 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs533276594 | chr2:152043362-152043363 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs144402856 | chr2:152043379-152043380 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs370106197 | chr2:152043386-152043387 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs551456686 | chr2:152043398-152043399 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs192092972 | chr2:152043460-152043461 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs4665028 | chr2:152043480-152043481 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs77808939 | chr2:152043481-152043482 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs74721817 | chr2:152043501-152043502 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs143411110 | chr2:152043532-152043533 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs568309365 | chr2:152043563-152043564 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs533768979 | chr2:152043564-152043565 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs180802889 | chr2:152043578-152043579 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs4665029 | chr2:152043588-152043589 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs539537400 | chr2:152043612-152043613 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs549081947 | chr2:152043614-152043615 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs567966818 | chr2:152043670-152043671 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs185421468 | chr2:152043713-152043714 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs35027829 | chr2:152043727-152043728 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs35036950 | chr2:152043782-152043783 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs576030560 | chr2:152043783-152043784 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs541783642 | chr2:152043784-152043785 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Mental retardation | 22214275 | CNVD |
Glioblastoma | 21080181 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 19156171 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Autism | 20808228 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:152045000-152045400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr2:152045000-152045800 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
3 | chr2:152045000-152046200 | Enhancers | Primary T cells from cord blood | blood |
4 | chr2:152045000-152046400 | Enhancers | Dnd41 | blood |